학술논문

Genetic variants of the nkg2c/hla-e receptor– ligand axis are determinants of progression-free survival and therapy outcome in aggressive b-cell lymphoma
Document Type
Article
Source
In: Cancers. (Cancers, November 2020, 12(11):1-12)
Subject
Language
English
ISSN
20726694